CORONA Remedies receives EU-GMP certification for hormone facility
Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets
Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
Subscribe To Our Newsletter & Stay Updated